Maridebart cafraglutide, a novel injectable GIP receptor antagonist/GLP-1 receptor agonist, reduced body weight by ...

According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...

UK investment bank Peel Hunt suggests food inflation could near 4% by the end of 2025 as supermarkets react to cost pressures arising from Labour’s budget in October.

The GLP-1s include semaglutide (Ozempic, Wegovy) and the combination of GLP-1/GIP drug tirzepatide (Mounjaro, Zepbound).

Madrigal Pharmaceuticals' strong launch is confirmed with impressive sales in Q1 and Q2. Learn why MDGL stock could benefit ...

As employers grapple with including GLP-1s in their benefits packages, they face a complex decision that boils down to two main factors: human resources and finance. On one side, there's the potential ...

Highmark Health President and CEO David Holmberg discussed the uncertainties facing the insurance industry, including the ...

"Yes, I am on a GLP-1 for a weight-loss medication,” the 'Queer Eye' star said Jonathan Van Ness is opening up on how ...

In January 2023, the world was abuzz with stories of a revolutionary weight-loss drug – a simple, self-administered injection ...

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...

Costco Wholesale Corp. on Wednesday reported a 9.9% year-over-year sales gain through the final stretch of the holiday shopping season, marked by a big jump in online sales.

Costco Wholesale Corp. on Wednesday reported a 9.9% year-over-year sales gain through the final stretch of the holiday shopping season, marked by a big jump in online sales.